Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiangiogenesis: current clinical data and future perspectives.

J Drevs1, C Laus, M Medinger

  • 1Klinik für Tumorbiologie, Freiburg, Germany. drevs@tumorbio.uni-freiburg.de

Onkologie
|February 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bloodstream infection with Candida kefyr/Kluyveromyces marxianus: case report and draft genome.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation.

Bone marrow transplantation·2017
Same author

Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.

Oncogene·2017
Same author

Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.

Oncogene·2017
Same author

Revisiting nutritional support for allogeneic hematologic stem cell transplantation-a systematic review.

Bone marrow transplantation·2017
Same author

Foreword.

Lipids·2016

Tumor growth and metastasis depend on new blood vessel formation (neovascularization). Inhibiting this process shows promise but requires understanding diverse human angiogenic phenotypes for effective cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Neovascularization is crucial for solid tumor growth and metastasis.
  • This process is regulated by proangiogenic and antiangiogenic factors, including VEGF, bFGF, and matrix-metalloproteinases.
  • Angiogenesis inhibition is a promising therapeutic strategy for malignant tumors, with successful preclinical data.

Purpose of the Study:

  • To provide an overview of key angiogenically active substances.
  • To review preclinical and clinical data on angiogenesis inhibition in cancer therapy.
  • To discuss surrogate markers and future perspectives in targeting tumor neovascularization.

Main Methods:

  • Literature review of scientific articles and clinical trial data.
  • Analysis of the roles of key angiogenic factors (VEGF, bFGF, MMPs).

Related Experiment Videos

  • Examination of preclinical and clinical outcomes of anti-angiogenic therapies.

    • Main Results:

    • Preclinical trials for angiogenesis inhibition have been highly successful.
    • Clinical studies show variable response rates, suggesting distinct human angiogenic phenotypes.
    • Current understanding of angiogenic cytokine interactions and regulatory systems is incomplete.

    Conclusions:

    • Angiogenesis inhibition is a vital therapeutic avenue for cancer, but clinical efficacy varies.
    • Further research is needed to elucidate complex angiogenic pathways and identify patient subgroups who benefit most.
    • Understanding diverse angiogenic phenotypes is critical for optimizing anti-angiogenic cancer treatments.